Not logged in Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Association Between Epstein-Barr Virus Infection and PD-L1 Expression in Gastric Cancer: Prevalence, Clinicopathological Features, and Prognostic Implications Wonglhow, Jirapat; Tantipisit, Jarukit; Wetwittayakhlang, Panu; Sunpaweravong, Patrapim; Sathitruangsak, Chirawadee; Kanjanapradit, Kanet; Thongwatchara, Phatcharaporn; Dechaphunkul, Arunee Share Save
Changing Landscape of Head and Neck Squamous Cell Carcinoma and Nasopharyngeal Carcinoma Treatment and Survival Trends in Thailand: A 13-Year Multicenter Retrospective Study of Patients Ngamphaiboon, Nuttapong; Dechaphunkul, Arunee; Vinayanuwattikun, Chanida; Danchaivijitr, Pongwut; Thamrongjirapat, Thanaporn; Prayongrat, Anussara; Dechaphunkul, Tanadech; Jiratrachu, Rungarun; Pattaranutaporn, Poompis; Jiarpinitnun, Chuleeporn; Setakornnukul, Jiraporn Share Save
Share Save
Comparative effectiveness analysis of survival with first-line palbociclib or ribociclib plus AI in HR + /HER2-advanced breast cancer (CEPRA study): preliminary analysis of real-world data from Thailand Dajsakdipon, Thanate; Susiriwatananont, Thiti; Wongkraisri, Concord; Ithimakin, Suthinee; Parinyanitikul, Napa; Supavavej, Archara; Dechaphunkul, Arunee; Sunpaweravong, Patrapim; Neesanun, Sunee; Akewanlop, Charuwan; Dejthevaporn, Thitiya Share Save
Share Save
BGB-A317-LBL-007-202: A phase 2, randomized, active-controlled, open-label study to evaluate the efficacy and safety of LBL-007 (anti-LAG-3) in combination with tislelizumab (TIS; anti-PD-1) plus chemotherapy (chemo) as first-line (1L) treatment in patients with unresectable locally advanced/metastatic esophageal squamous cell carcinoma (ESCC) Park, Sook Ryun; Chen, Ming-Huang; Dechaphunkul, Arunee; Ding, Ningning; Lin, Xiao; Zhang, Jinghui; Li, Vivian; Li, Qiao; Ba, Yi Share Save
IMvoke010: A phase III, double-blind randomized trial of atezolizumab (atezo) after definitive local therapy vs placebo in patients (pts) with high-risk locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN) Wong, Deborah J.; Fayette, Jerome; Teixeira, Maria; Prabhash, Kumar; Mesia, Ricard; Kawecki, Andrzej; Dechaphunkul, Arunee; Dinis, Jose; Guo, Ye; Masuda, Muneyuki; Hsieh, Ching-Yun; Ghi, Maria Grazia; Sette, Claudia Vaz de Melo; Jiang, Tao; Yan, Yibing; Kaul, Monika; Jagtiani, Ritika; Matheny, Christina; Cuchelkar, Vaikunth; Haddad, Robert Share Save
Share Save
Summary of Research: Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC Tsuboi, Masahiro; Herbst, Roy S.; John, Thomas; Kato, Terufumi; Majem, Margarita; Grohe, Christian; Wang, Jie; Goldman, Jonathan W.; Lu, Shun; de Marinis, Filippo; Shepherd, Frances A.; Lee, Ki Hyeong; Le, Nhieu Thi; Dechaphunkul, Arunee; Kowalski, Dariusz; Bonanno, Laura; Domine, Manuel; Poole, Lynne; Bolanos, Ana; Rukazenkov, Yuri; Wu, Yi-Long Share Save
Share Save